Work

MYD88 L265P mutation and CDKN2A loss as early mutational events in primary central nervous system lymphomas.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.e14041

Authors: Michael White, Priscilla Kaliopi Brastianos, Tracy Batchelor, Naema Nayyar, Corey Gill, Matt Lastrapes, Mia Bertalan, Alex Kaplan, Meghan D'Andrea, Ivanna Bihun, Andrew Kaneb, Jorg Dietrich, Judith Ferry, Maria Martinez-Lage Alvarez, Anita Giobbie-Hurder, Darrell R. Borger, Fausto J Rodriguez, Matthias Holdhoff, Daniel P. Cahill, Scott L. Carter

Institutions: Massachusetts General Hospital, Icahn School of Medicine at Mount Sinai, Dana-Farber Cancer Institute, Harvard University, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Broad Institute

Language: English

Topic: CNS Lymphoma Diagnosis and Treatment

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2892042628

Cites:

Cited by: 1

Related to: 10